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Abstract
Background: Cognitive behavioral therapy (CBT) is an effective intervention to treat depressive disorders in youth. However,
50% of adolescents still have depressive symptoms after treatment, and 57% drop out during treatment. Online CBT interventions
have proven to be effective in reducing depressive symptoms and seem promising as a treatment for depressed adolescents.
However, combining online programs with face-to-face sessions seems necessary to increase their effectiveness and monitor for
suicide risk.
Objective: In this study, we examine the effectiveness and cost-effectiveness of a blended CBT treatment protocol, a mixture
of online and face-to-face CBT, as a treatment for clinically depressed adolescents.
Methods: A pragmatic quasi-experimental controlled trial will be conducted to study the effectiveness of a blended CBT
treatment protocol, in which blended CBT is compared with face-to-face CBT (n=44) and treatment as usual (n=44); the latter
two were collected in a previous randomized controlled trial. The same inclusion and exclusion criteria will be used: adolescents
aged between 12 and 21 years, with a clinical diagnosis of a depressive disorder, and referred to one of the participating mental
health institutions. Assessments will be conducted at the same time points: before the start of the intervention, during the intervention
(after 5 and 10 weeks), postintervention, and at 6- and 12-month follow-ups.
Results: The primary outcome is the presence of a depression diagnosis at 12-month follow-up. Several secondary outcomes
will be measured, such as depressive symptoms, quality of life, and suicide risk. Costs and effects in both conditions will be
compared to analyze cost-effectiveness. Further, moderating (age, gender, alcohol and drug use, parental depression, and other
psychopathology) and mediating effects (negative automatic thoughts, cognitive emotion regulation, attributional style) will be
analyzed. Also, treatment characteristics will be studied, such as characteristics of the therapists, treatment expectancy, and
therapeutic alliance. Dropout rates and treatment characteristics will be measured to study the feasibility of blended CBT.
Conclusions: This study will examine the effectiveness and cost-effectiveness of a blended CBT program in which depressed
adolescents are treated in mental health care. Results of blended CBT will be compared with face-to-face CBT and treatment as
usual, and implications for implementation will be reviewed.
Trial Registration: Dutch Trial Register (NTR6759); http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=6759
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Introduction
Depressive disorders are among the most prevalent mental health
disorders in adolescents [1]. They have a substantial effect on
well-being, a high burden of disease, and a high risk of
recurrence and chronicity [1,2]. At the age of 18 years, more
than 15% of adolescents have suffered from a major depressive
disorder [3]. Depression shows high comorbidity with other
mental health diagnoses and increased social problems,
decreased academic performance, increased school dropouts,
more substance abuse, and an increased risk of suicide attempts
and suicide [1,2,4]. Therefore, it is crucial that depressive
disorders are treated effectively at an early age. In this study,
we will test the effectiveness and cost-effectiveness of a blended
treatment protocol [5] that combines internet-based and
face-to-face sessions in an integrated treatment protocol
targeting depressive symptoms in clinically depressed
adolescents.
Several meta-analyses have shown that cognitive behavioral
therapy (CBT) is an effective intervention to treat adolescent
depression [6,7]. However, the effect size of CBT was found
to be moderate (Cohen’s d=0.53) [7], and 50% of the adolescents
were not free of depressive symptoms after being treated [8].
A recent Dutch randomized controlled trial (RCT) showed that
the D(o)epression protocol (face-to-face individual CBT) was
equally effective as treatment as usual (TAU; for example,
interpersonal therapy, family therapy, medication, mindfulness
training, creative therapy, and running therapy) in reducing
depressive symptoms, as assessed by the Children’s Depression
Inventory 2, and depressive disorders, as assessed by the
semistructured interview Kiddie Schedule for Affective
Disorders and Schizophrenia (K-SADS) [9,10]. Despite this
result, a significant number of adolescents were not free of
depressive symptoms at posttreatment (24%), the effects were
moderate, the dropout was high (57%), and it was hard to
motivate patients to finish the treatment. Therefore, it is
important to develop an attractive and more suitable treatment
for adolescents who do not prefer to visit a mental health
professional each week. Exploring possibilities to improve
existing treatments in an innovative manner with recently
developed technologies to reach out to patients may prove a
fruitful strategy.
One way to improve the flexibility and attractiveness of
treatment of depressed adolescents is to offer online CBT.
Earlier research showed that online CBT and face-to-face CBT
had, on average, similar effects in the treatment of depressive
disorders in adults [11-14]. It is suggested that online
interventions can increase treatment motivation and expectancies
for some patients and might decrease resistance because they
can be easily tailored to the adolescents’ needs and adjusted to
their daily lives [15]. Another benefit is that online interventions
seem more easily accessible for adolescents. Only 25% of the
adolescents who suffer from depression receive treatment, so
improving access to treatment is crucial [16]. Furthermore,
adolescents appear to prefer to work autonomously on their
treatment, which is typical for online interventions [15]. Online
interventions increase independence and self-confidence of
patients because patients can choose when and how often they
work on the intervention. It also strengthens their competences
[17] and can enhance social support by peers through online
chat [18]. For these reasons, online CBT is a promising
intervention.
However, when treating depression, face-to-face contact with
therapists is strongly advised because the suicide risk has to be
monitored. Therefore, treatment that is only offered online, such
as online CBT, might not be sufficient for depressed adolescents.
There are several therapist-supported options that can be
combined with online treatment. Some treatment protocols offer
online CBT combined with support or guidance by a therapist
through encrypted email or online chat, called guided CBT.
Several systematic reviews found that therapist guidance in
guided or blended CBT increases the effectiveness of online
interventions and is also associated with higher completion of
the treatment [11,12,19]. The so-called blended treatment
protocols could even be more appropriate or adequate for
depressed adolescents. In blended treatments, the online protocol
and face-to-face sessions are fully integrated into one treatment
protocol. These blended treatment protocols might contain the
optimal combination of flexibility and attractiveness for
adolescents and possibilities to monitor progression and risk
for therapists during the face-to-face sessions.
Health care costs of depression treatment could potentially be
reduced by offering CBT in a blended form compared with
face-to-face CBT or TAU because some face-to-face sessions
with a therapist are replaced by an online program. Fewer
face-to-face sessions per patient are needed; therefore, therapists
can treat more patients, which in turn can decrease the duration
of waiting lists [17]. Both improving access and reducing
waiting lists might allow more patients to benefit from treatment
and, eventually, societal costs may be reduced as well [20]. In
sum, blended treatment, defined as a combination of online
treatment and face-to-face sessions, might be the solution to
optimize the effectiveness of CBT for depressive adolescents
by increasing motivation and expectancy, decreasing resistance
(and dropouts), and tailoring the treatment [15,17], which will
likely lead to reduced costs [20]. However, the effectiveness
has never been studied before in clinically depressed adolescents
who are referred for treatment [21]. The treatment protocol
D(o)epression Blended was specifically developed to treat
depressive disorders in clinically referred adolescents [22].
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This study will examine the effectiveness and cost-effectiveness
of D(o)epression Blended compared with D(o)epression
face-to-face and TAU in clinically depressed adolescents. The
adolescents in the latter two conditions already participated in
a previous study comparing CBT with TAU using an RCT
design [9,10]. Blended CBT treatment is expected to be more
effective than TAU. Additionally, we expect blended CBT to
be equally effective as face-to-face CBT. We also will study
the intervention effect of depression severity, quality of life,
suicide risk, and comorbidity. The costs of the interventions in
the three conditions will be compared to analyze the
cost-effectiveness. In addition to examining the effectiveness
and cost-effectiveness, we will examine who the intervention
is effective for by testing several moderators (age, gender,
ethnicity, family income, alcohol and drug use, life events,
degree of conflicts, parental depression, and other
psychopathology) and how the intervention works by studying
several mediators (negative automatic thoughts, cognitive
emotion regulation, attributional style). Furthermore, treatment
characteristics will be studied; that is, characteristics of the
therapists, treatment expectancy, previous treatments, treatment
satisfaction, therapeutic alliance, cooperation with treatment,
and dropout rates to see whether the feasibility of D(o)epression
Blended differs from face-to-face CBT and TAU, and whether
these factors are related to the implementation and execution
of the treatment program.
Methods
Design
This study will use a pragmatic quasi-experimental controlled
trial design with one condition to evaluate the effectiveness and
cost-effectiveness of blended CBT. Data from a previously
conducted RCT, in which face-to-face CBT was compared to
TAU, will be used to compare the different treatments.
Therefore, this can be seen as a third additional condition to the
previously conducted RCT.
A new cohort will be measured and treated in this study. The
assessments and instruments will be identical to the previous
study comparing CBT to TAU. Assessments will be conducted
at baseline (T0), during the intervention after 5 weeks (T1),
during the intervention after 10 weeks (T2), at 1 to 4 weeks
postintervention (T3), at 6 months follow-up (T4), and at 12
months follow-up (T5). The overall study design is shown in
Figure 1.
For the adolescents, it will take an estimated 60 minutes for T0;
40 minutes for T3, T4, and T5; and 30 minutes for T1 and T2.
For parents, the measurements will take an estimated 45 minutes
for T0, T3, T4, and T5, and an estimated 5 minutes for T1 and
T2. For the therapist, T0 will take 3 minutes, and T1, T2, and
T3 will take 1 minute to complete. Time estimations are based
on earlier studies [10].
The study was approved by the medical ethics committee of the
University Medical Centre Utrecht in the Netherlands
(NL61804.041.17). Details are described according to the
SPIRIT (Standard Protocol Items: Recommendations for
Interventional Trials) guidelines [23]. The study was registered
prospectively in the Dutch Trial Register (NTR6759) on October
16, 2017.
JMIR Res Protoc 2019 | vol. 8 | iss. 10 | e13434 | p. 3https://www.researchprotocols.org/2019/10/e13434
(page number not for citation purposes)
Rasing et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Figure 1. Overall study design. T0=baseline; T1=during the intervention after 5 weeks; T2=during the intervention after 10 weeks; T3=at 1 to 4 weeks
postintervention; T4=at 6 months follow-up; T5=at 12 months follow-up.
Participants’ Eligibility
In total, 70 clinically depressed adolescents referred for
treatment in one of nine participating mental health institutions
will be asked to participate in this study, together with one of
their parents. If the adolescent is 16 years or older, parents will
only be approached with the adolescent’s permission. Inclusion
criteria for the adolescents are (1) having a clinical diagnosis
of a depressive disorder, (2) aged between 12 and 21 years, and
(3) referred to one of the participating mental health institutions.
Exclusion criteria are (1) acute risk of suicide, (2) drug abuse
(as primary diagnosis), (3) pervasive developmental disorder
(as primary diagnosis), (4) bipolar disorder (as primary
diagnosis), (5) day care or admission to the clinical setting, and
(6) insufficient knowledge of the Dutch language. If participants
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use medication, the dosage will be kept constant during the
intervention.
Recruitment
Adolescents with a depressive disorder referred for treatment
in psychiatric care and their parents will be informed about the
study and asked to participate. Researchers will obtain written
informed consent from adolescents, and parents when
adolescents are younger than 16 years, before enrolling
participants in this study. Additional written informed consent
will be obtained from parents when they participate in the study.
All adolescents meeting the eligibility criteria and willing to
participate will be assigned to the D(o)epression Blended
intervention.
Sample Size
The sample size (N=70) is equal to the sample size of the RCT
that was already conducted in which D(o)epression face-to-face
was compared with TAU. The data from this study will be
compared with data from that RCT. The power analysis used
in the previously conducted RCT was based on the difference
between CBT and TAU at posttreatment. A meta-analysis on
the effectiveness of CBT showed an effect size of 0.53 for CBT
when delivered face-to-face [7]. Based on a meta-analysis on
online interventions for depression (among which preventive
interventions), the effect size was 0.76 [14]. Based on the
literature, we assume that the effect size of blended CBT is
equal to face-to-face CBT. We hypothesize that D(o)epression
Blended is more effective than TAU. Furthermore, we will
exploratively compare D(o)epression Blended to D(o)epression
face-to-face. To detect the difference in depression diagnoses
between the conditions of the previous study comparing blended
CBT with TAU and this study, assuming alpha=.05 with a power
of (1-β)=0.80 and dropout of 20% (power calculations in Stata),
70 adolescents will be included in this study.
Intervention
D(o)epression Blended [22] is an adaptation of the Dutch
D(o)epression face-to-face program [24]. D(o)epression
face-to-face is an individual CBT program based on the
evidence-based treatment program Coping with Depression
course for Adolescents [24]. All 15 sessions of the original
D(o)epression face-to-face protocol were adapted for use in an
online environment in four modules. Major adaptations included
a shortening of the wording, more use of attractive visuals, and
the possibility to interact online with the therapist. The online
program can be combined with a minimum of 5 and maximum
of 15 face-to-face sessions. The face-to-face sessions last 45
minutes each, and the adolescent and the therapist are present.
Face-to-face sessions are scheduled when the adolescent starts
with a new online module and at the end of the treatment, as is
advised in the manual. More face-to-face sessions can be added
when the therapist considers this helpful or necessary, with a
maximum of 15. Additionally, there is unlimited contact
between the adolescent and therapist through a chat function
within the program. During the face-to-face contacts, online
modules are introduced, the therapist invests in the therapeutic
relationship, exercises are practiced, and suicide risk is
examined. There are also two face-to-face contacts with the
parents (when parents are involved): after 3 weeks and after the
start of the fourth module. Parents receive psychoeducation,
information about CBT, and suggestions on how parents can
contribute to the treatment. All CBT therapists who will offer
the D(o)epression Blended as treatment were trained by a
registered clinical psychologist in how to provide blended
treatment and in working with this specific blended treatment
protocol in a 1-day training session.
The content of D(o)epression Blended is the same as that of the
face-to-face intervention and consists of the following
components: psychoeducation, setting realistic goals,
self-monitoring, activation, improvement of social and
communication skills, relaxation skills, cognitive restructuring,
role play, problem-solving skills, and relapse prevention [25].
These components are divided into four online modules, which
are offered sequentially and are called Start, Do, Think, and
Future. The monitoring of mood and activities is completely
online. The exercises are introduced during the face-to-face
contacts and are practiced online and at home, which increases
the generalizability to real-life situations. The therapist receives
automatically generated prompts when the adolescent has
completed a task and can view the content of the task. The online
environment offers convenience, autonomy, and flexibility
because adolescents can tailor their treatment preferences, such
as pace, frequency, and location. This means that blended
treatment is vastly different from regular treatment and allows
for tailoring of the treatment to the preferences of each
individual.
The control condition is TAU, which consists of a broad range
of different treatments. Mental health institutions offer
interpersonal therapy, family therapy, parent counseling,
medication, mindfulness training, ACT (acceptance commitment
therapy), psychodynamic therapy (short duration), (nondirective)
counseling, creative therapy, and running therapy. For research
purposes, CBT is not allowed within TAU.
Study Outcome Measures
For an elaborate overview of study variables, see Table 1.
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Table 1. Overview of study variables.
AssessmentSourceInstrumentType of variable and concept
T5fT4eT3dT2cT1bT0aTherapistParentAdolescent
Primary outcome


















xxxxxSuicide Risk TaxationSuicide risk taxation
xxxxxxYouth Self-Report scale/










Gender, age, ethnicity, ed-
ucation, income
xxxxxSchool QuestionnaireSchool or work
xxxxxAlcohol and DrugsAlcohol and drugs






























xxxService Satisfaction ScaleSatisfaction treatment
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bT1=during the intervention after 5 weeks.
cT2=during the intervention after 10 weeks.
dT3=at 1 to 4 weeks postintervention.
eT4=at 6 months follow-up.
fT5=at 12 months follow-up.
Primary Outcome Measure
Presence of the diagnosis of depression will be measured by
the Present and Lifetime version of KSADS (K-SADS-PL)
[26,27]. This widely used semistructured diagnostic interview
assesses a wide range of diagnoses (present and lifetime),
including their severity, taking into account the view of the
adolescent and the parent, and will be conducted by a trained
independent research assistant. Concurrent validity of the
K-SADS-PL is supported; interrater agreement is high
(93%-100%), and test-retest reliability is excellent for present
and lifetime diagnoses of major depression [26].
Secondary Outcome Measures
Depressive symptoms will be measured with the Dutch version
of the self-report measure Child Depression Inventory 2 [28,29],
and with the Child Depression Inventory 2 parent version [28]
rated by the parent. The severity of the depression will be
assessed using the K-SADS-PL [26]. Severity of depression
will also be assessed with the Clinical Global
Impression-Severity scale [30], and improvement of depression
will be assessed with the Clinical Global
Impression-Improvement scale [30], both rated by the therapist.
Global functioning of the adolescent will be assessed with the
therapist-rated Children Global Assessment Scale [31,32].
Suicide risk will be assessed with the K-SADS-PL [26], as well
as with a self-report questionnaire Suicide Risk Taxation, which
focuses on the frequency of suicidal thoughts, wishes, plans,
and actions over the past 2 weeks. Comorbidity and
psychopathology will be assessed with the K-SADS-PL [26],
and additionally with the Youth Self-Report scale [33,34], rated
by adolescents, and with the Child Behavior Check List for
parents [33,34].
Cost-Effectiveness Measures
Health-related quality of life will be measured with the Dutch
version of the EuroQol Questionnaire (EQ-5D-Y) [35] and with
the parent-rated EuroQol Questionnaire (EQ-5D proxy version)
[35], which will be used to calculate quality-adjusted life-years.
The economic evaluation will be performed by registration of
health care usage and costs in a cost questionnaire with a recall
period of 3 months, which will be filled out by parents (which
is identical to the one used in the previous RCT). Health care
usage and registered costs that will be assessed are direct health
care costs (eg, costs of psychologist, general practitioner, online
treatment program, and medication), direct non-health care costs
(eg, informal care), indirect costs (eg, monetary value of
production losses caused by absence and reduced productivity
and school), and out-of-pocket costs (eg, own contribution and
transport costs). Costs will be calculated from a mental health
care view and a societal view. The units of health care usage
(eg, contact with the general practitioner, a session with a
psychologist, costs of the online program) will be multiplied
by the standard cost price obtained from the Dutch costing
manual [36].
Moderators
Demographic information about the adolescents and parents
will be assessed at baseline. Alcohol and drug use of the
adolescents will be registered. Life events (such as bereavement,
maltreatment, and suicide attempts), the date of occurrence, and
their impact on the adolescent’s well-being will be registered
with the Life Event Scale [37] by the adolescent and parent.
The Network of Relationships Inventory will be filled in by
both adolescents and parents to measure the degree of conflicts,
such as quarrels, irritations, and antagonism, in the child-parent
relationship [38]. Depressive symptoms in parents will be
assessed with the Dutch version of the Beck Depression
Inventory, second edition [39]. Parental psychopathology will
be assessed with the Adult Self-Report [40].
Mediators
Negative cognitive errors will be measured with the Negative
Cognitive Error Questionnaire [41], which consists of the
subscales underestimation of the ability to cope, personalizing
without mind reading, selective abstraction, overgeneralizing,
and mind reading. Cognitive emotion regulation will be assessed
with the Cognitive Emotion Regulation Questionnaire [42]
consisting of several strategies as a response to experiencing
stressful events, namely self-blame, other blame, rumination,
catastrophizing, positive refocusing, planning, positive
reappraisal, putting into perspective, and acceptance.
Attributional style will be measured with the self-report
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Children’s Attributional Style Questionnaire [43], which
contains three dimensions of attribution, namely
internal-external, stable-unstable, and global-specific.
Treatment Characteristics
At baseline, demographic information and information about
education and experience of therapists will be assessed.
Treatment expectancy will be measured with the Parent
Expectancies for Therapy Scale [44], which will also be rated
by adolescents in a revised version. Previous treatments for the
adolescents’ depression, such as CBT, pharmacotherapy,
self-help treatments, or alternative therapies, will also be
reported by the adolescents and parents with the inventory of
History of Treatments [45]. Adolescents’ and parents’
satisfaction with treatment will be assessed with the Service
Satisfaction Scale [46]. Therapeutic alliance will be reported
by the adolescent and therapist using the Therapeutic Alliance
Scale for Children [47]. The degree of cooperation with
treatment, as observed by the therapist, will be measured with
the Cooperation With Treatment scale [48]. The content of
treatment will be assessed with some questions on the procedure
during the therapy, such as techniques used and amount of
contact through email and chat. Treatment integrity will be
checked by recording two randomly chosen sessions per patient
that will be observed and rated by trained psychologists. Ratings
will be based on the quality of the therapist (eg, empathy,
motivating patient), content of treatment (eg, following protocol,
attaining goals), and structure of the session (eg, setting agenda,
following time schedule). Items will be rated on a scale from 0
to 3, in which 0=absent, 1=minimal, 2=largely, and 3=maximal.
A mean score for treatment integrity will be calculated.
Analyses
Intention-to-treat (imputed data) analyses and completer-only
analyses will be conducted. Results will be reported in
accordance with the CONSORT (Consolidated Standards of
Reporting Trials) 2010 Statement [49].
Preliminary Analyses
Possible baseline differences in demographic and diagnostic
characteristics between the three conditions—(1) D(o)epression
Blended condition, (2) D(o)epression face-to-face condition,
and (3) TAU condition (the latter two conditions from the RCT,
which has already been conducted)—will be checked by means
of ANOVA, MANOVA, and chi-square analyses. If these
variables show differences between the conditions, they will be
entered as covariates in all models and regression models to
test the effectiveness of the intervention.
Analysis of Primary Outcome
The primary outcome measure (ie, presence of depression
diagnosis) is dichotomous and will be tested with logistic
regression analyses comparing the percentage of depressive
disorders in the D(o)epression Blended condition in this study
to the percentage of depressive disorders in the D(o)epression
face-to-face condition and the TAU condition from the previous
RCT.
Analysis of Secondary Outcomes
The intervention impact on the secondary outcomes (depression
symptoms, depression severity, depression improvement, quality
of life, suicide risk, comorbidity) will be evaluated using linear
mixed modeling with the baseline level of the concerning
variable as the covariate.
Cost-Effectiveness Analyses
A cost-effectiveness analysis will be conducted by comparing
the costs and effects of the D(o)epression Blended condition in
this study to the costs and effects and effects of D(o)epression
face-to-face and TAU. The economic evaluation will be
executed in accordance with the CHEERS (Consolidated Health
Economic Evaluation Reporting Standards) Statement [50,51],
which has been successfully executed previously in an economic
evaluation of treatment of anxiety disorders in children [52].
The costs of blended CBT versus face-to-face CBT and TAU
will be expressed in (1) incremental costs per adolescent with
a depression in full remission (based on the K-SADS-PL) and
(2) incremental costs per quality-adjusted life year (based on
the EuroQol). To gain insight into the uncertainty surrounding
subtotal and total costs, and due to highly skewed cost
distributions, bootstrap simulations (1000 replications) will be
conducted. Bootstrap simulations will be conducted to quantify
the uncertainty around the incremental cost-effectiveness ratio
[53], yielding information about the joint distribution of cost
and effect differences. The bootstrapped cost-effectiveness ratios
will be subsequently plotted in a cost-effectiveness plane. The
bootstrapped incremental cost-effectiveness ratios will also be
depicted in a cost-effectiveness acceptability curve showing the
probability that a condition is cost-effective using a range of
ceiling ratios. Also, sensitivity analyses will be performed to
test the robustness of the results. The cost-effectiveness analyses
will be done separately from a mental health perspective and a
societal perspective over a period of 6 months and 1 year.
Analyses of Moderators
We will conduct a series of a priori planned moderator analyses
to see if the intervention effect is moderated by the following
moderators: adolescent characteristics (age, gender, ethnicity,
family income), alcohol and drug use, life events, degree of
conflicts, parental depression, and parental psychopathology.
Analyses of Mediator
Determining possible mediators that influence the effect of the
intervention helps to identify the working mechanisms of the
blended intervention. More specifically, we will test if the
intervention effect on the presence of a depression diagnosis is
mediated by changes in negative cognition, cognitive emotion
regulation, and attributional style. The mediation analyses will
be performed in Mplus [54], where indirect effects will be tested
with bootstrap methods.
Other Analyses
We will also conduct analyses to see whether the feasibility of
D(o)epression Blended differs from face-to-face CBT and TAU
on treatment expectancy, previous treatments, satisfaction with
treatment, cooperation with treatment, relationship with the
therapist, treatment integrity, and dropout rate, and whether
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these factors are related to the implementation and execution
of the treatment program.
Results
Overview
The primary outcome is the presence of a depression diagnosis
at 12-month follow-up. Several secondary outcomes will be
measured, such as depressive symptoms, quality of life, and
suicide risk. Costs and effects in both conditions will be
compared to analyze cost-effectiveness. Further, moderating
(age, gender, alcohol and drug use, parental depression, and
other psychopathology) and mediating (negative automatic
thoughts, cognitive emotion regulation, attributional style)
effects will be tested. Also, treatment characteristics will be
studied, such as characteristics of the therapists, treatment
expectancy, and therapeutic alliance. The dropout rate and
treatment characteristics will be measured to study the feasibility
of blended CBT.
Ethics Approval and Consent to Participate
The study will be conducted according to the principles of the
World Medical Assembly Declaration of Helsinki (2013) and
in accordance with the Dutch Medical Research Involving
Human Subjects Act (in Dutch: WMO) and other guidelines,
regulations, and acts. Ethical approval has been obtained after
extensive peer review by the medical ethics committee
University Medical Centre Utrecht, The Netherlands
(NL61804.041.17). The study is registered in the Dutch Trial
Register (Trial ID: NTR6759). The study results will be reported
in accordance with the CONSORT 2010 statement for reporting
randomized trials [49]. Written informed consent to participate
in the study will be obtained from adolescents and parents.
Funding Status
This research was funded in December 2016 by the Dutch
Organization for Health Research and Development ZonMW
(grant number 70-72900-98-16144).
Recruitment
The trial began recruiting participants in November 2017, and
end of study enrollment was March 2019. At this time, 42
children have been recruited.
Trial Status
We are in the process of conducting the 6- and 12-month
follow-up assessments. The first results are expected to be
submitted for publication in 2020.
Datasets
The datasets used and/or analyzed during this study will be
available from the corresponding author on reasonable request.
Discussion
Summary
This study protocol describes a pragmatic quasi-experimental
controlled trial investigating the effectiveness and
cost-effectiveness of a blended CBT treatment protocol in
clinically depressed adolescents. Results of D(o)epression
Blended will be compared with D(o)epression face-to-face and
TAU. Data from the latter two conditions already have been
collected in a previous study comparing CBT with TAU using
an RCT design [9,10]. Testing the effectiveness of blended
treatment is in accordance with the suggestions made by Calear
and Christensen [55] and Richardson et al [56] to compare a
blended treatment, such as blended CBT, to other active
interventions, such as face-to-face CBT and TAU. Furthermore,
we will examine the role of several moderators (comorbidity,
depression severity, age, ethnicity, gender, family income,
parental psychopathology) and mediators (negative automatic
thoughts, cognitive emotion regulation, attributional style) to
study who the intervention is effective for and how the
intervention works. In this way, the study responds to
unanswered questions about the moderators and mediators of
blended interventions [6,57]. In addition, important factors in
blended interventions, such as the dropout rate, feasibility,
treatment expectancy, satisfaction with treatment, cooperation
with treatment, relationship with the therapist, and treatment
integrity will be studied.
Strengths and Limitations
One of the strengths of this study is that it is carried out in
mental health institutions and that the targeted population of
this study consists of adolescents referred for treatment of their
depressive disorder. Participants were not recruited for treatment
for the purpose of this study. This means that conclusions from
the results of this research can be generalized to real-life mental
health care. Additionally, the study will be conducted in several
mental health care centers in the Netherlands. Therefore, our
findings will not be based on the results of only one mental
health institution, which adds to the generalizability of the
results. Another strength is that we will compare a blended CBT
treatment protocol to active treatment conditions: face-to-face
CBT and TAU. Moreover, assessments will be based on multiple
informants (ie, adolescents, parents, and therapists).
This innovative blended treatment has considerable potential.
It incorporates the positive characteristics of online
interventions, such as high accessibility, and the potential to be
easily tailored to the daily lives of adolescents. To our
knowledge, this is the first study on the effectiveness of blended
CBT treatment of depressive disorders in adolescents. Therefore,
we can uniquely contribute to the crucial evidence-based
improvement of treatment protocols in mental health care.
A limitation is that the study is not designed as an RCT. In this
study, we will recruit participants for the blended CBT condition
only. The results of these participants will be compared with
participants recruited in the earlier conducted RCT, in which
face-to-face CBT was compared to TAU. Since there is no
randomization in the current trial, it cannot be ruled out that
there are slight differences in the participants, therapists, or
societal context. We will try to keep this potential threat to
internal validity as low as possible by working with the same
inclusion and exclusion criteria for participants and with the
same or similar mental health institutions. However, this
pragmatic quasi-experimental design will deliver preliminary
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evidence and very relevant information on the effectiveness and
cost-effectiveness of blended CBT in routine care.
Implications for Practice
If the blended CBT program D(o)epression Blended proves to
be effective and cost-effective in treating depressive disorders
in adolescents in mental health care, then D(o)epression Blended
could be widely implemented in mental health institutions. This
could expand the treatment choices of depressive disorders in
adolescents and improve the potential to tailor and personalize
the treatment.
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